tranylcypromine has been researched along with Depressive Disorder, Treatment-Resistant in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, M; Findeis, H; Ludwig, VM; Ritter, P; Rucker, J; Sauer, C; Young, AH | 1 |
| Appolinário, JC; Bueno, JR; da Rocha Freire, RC; Ferreira-Garcia, R; Halkjær-Lassen, RD; Levitan, MN; Nardi, AE | 1 |
| Carvalho, AF; Goulia, P; Hyphantis, TN; Macêdo, DS | 1 |
| Deliyannides, DA; McGrath, PJ; Stewart, JW | 1 |
| Bartova, L; Kasper, S; Naderi-Heiden, A; Praschak-Rieder, N; Stamenkovic, M; Vogl, SE; Willeit, M | 1 |
| Bosanac, P; Castle, D; Menkes, D | 1 |
| Quante, A; Zeugmann, S | 1 |
1 review(s) available for tranylcypromine and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
MAOIs - does the evidence warrant their resurrection?
Topics: Anxiety Disorders; Bipolar Disorder; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Monoamine Oxidase Inhibitors; Phenelzine; Phobia, Social; Randomized Controlled Trials as Topic; Tranylcypromine | 2016 |
1 trial(s) available for tranylcypromine and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
How treatable is refractory depression?
Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dextroamphetamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Compounds; Male; Middle Aged; Nortriptyline; Phenelzine; Tranylcypromine; Treatment Outcome | 2014 |
5 other study(ies) available for tranylcypromine and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study.
Topics: Administration, Intravenous; Adult; Aged; Antidepressive Agents; Blood Pressure; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Drug Interactions; Female; Heart Rate; Humans; Injections, Subcutaneous; Ketamine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Retrospective Studies; Tranylcypromine; Young Adult | 2021 |
Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term Study.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cohort Studies; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Retrospective Studies; Time Factors; Tranylcypromine | 2018 |
N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Drug Synergism; Female; Humans; Male; Monoamine Oxidase Inhibitors; Remission Induction; Tranylcypromine; Treatment Outcome; Young Adult | 2013 |
Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Female; Humans; Inpatients; Ketamine; Monoamine Oxidase Inhibitors; Suicide Prevention; Tranylcypromine | 2015 |
Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Tranylcypromine | 2012 |